Regeneron Pharmaceuticals (REGN) in the Warm zone: what does the evidence show?
Regeneron Pharmaceuticals (REGN) has a Therm Score of 72.06 today, in the Warm zone. Across the full covered universe (S&P 500, Dow 30 and Nasdaq-100 — 520 assets), when the score has been in this zone, price has risen over the following 21 sessions in 90.9% of the independent episodes analyzed (median: +2.59%, net of trading costs, n=11 episodes).
This reflects aggregate historical behavior across the covered universe, not a prediction specific to Regeneron Pharmaceuticals (REGN). Score calculated on September 5, 2026 using institutional market data, updated daily.
The chart above shows Regeneron Pharmaceuticals (REGN)'s own history. The statistical validation cited in the text is based on the covered universe as a whole (S&P 500, Dow 30, Nasdaq-100 — 520 assets), not on this asset in isolation.
About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses.
Health Care peers
Other Health Care assets in the covered universe, by Therm Score today — not a recommendation, just context.
Frequently asked questions about Regeneron Pharmaceuticals (REGN)
Is now a good time to buy Regeneron Pharmaceuticals (REGN)?+
The Therm Score doesn't give buy or sell recommendations — it's non-personalized historical statistical information. Today Regeneron Pharmaceuticals (REGN) has a Therm Score of 72.1 (Warm zone); the covered universe shows what has historically happened when the indicator has scored similarly. This doesn't replace professional financial advice or account for your personal situation.
What is the price prediction for Regeneron Pharmaceuticals (REGN)?+
This tool doesn't make price predictions or set price targets. Instead, it shows the historical frequency with which price has risen or fallen after a similar score — across the covered universe as a whole, not a specific forecast for Regeneron Pharmaceuticals (REGN).
Is Regeneron Pharmaceuticals (REGN) overbought or oversold?+
According to the Therm Score, Regeneron Pharmaceuticals (REGN) is in the Warm zone today (72.1/100), based on normalized technical positioning relative to its own historical range.
Is Regeneron Pharmaceuticals (REGN) a good long-term investment?+
The Therm Score measures short-to-medium-term technical positioning (horizons of 5 to 21 sessions) — it isn't a fundamental analysis tool and doesn't assess Regeneron Pharmaceuticals's quality as a long-term investment.
Can I trust this indicator to invest?+
It's based on a validated historical backtest across the covered universe, with controls to avoid overfitting — but like any indicator based on past data, it doesn't guarantee future results.
How often is the Regeneron Pharmaceuticals (REGN) Therm Score updated?+
The score is recalculated every day after market close, using the most recent closing data available.